half life bpc 157 bpc-157 pharmacokinetics half-life study Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review BPC-157 Half-Life and Pharmacokinetics -

NICE and British Society for Haematology guidelines recommend: Initial treatment with hydroxocobalamin (the preferred form in the UK) via intramuscular injection For patients without neurological involvement: 1 mg IM three times a week for 2 weeks For patients with neurological involvement: 1 mg IM on alternate days until no further improvement Maintenance: 1 mg every 3 months for patients without neurological involvement

Always wash hands and sanitize the working area before beginning the process

Natural origin doesnt automatically mean safe, and BPC157 is not a vitamin or herbal supplement

The cost per vial reconstituted is negligible